218 related articles for article (PubMed ID: 23919889)
21. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
[TBL] [Abstract][Full Text] [Related]
22. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
Davoodi N; Kalinichev M; Korneev SA; Clifton PG
Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
[TBL] [Abstract][Full Text] [Related]
23. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
[TBL] [Abstract][Full Text] [Related]
24. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats.
Yang CP; Wang YY; Lin SY; Hong YJ; Liao KY; Hsieh SK; Pan PH; Chen CJ; Chen WY
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717287
[TBL] [Abstract][Full Text] [Related]
25. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
Fell MJ; Marshall KM; Williams J; Neill JC
J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
[TBL] [Abstract][Full Text] [Related]
26. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
Lian J; Huang XF; Pai N; Deng C
Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
[TBL] [Abstract][Full Text] [Related]
27. The role of thermogenesis in antipsychotic drug-induced weight gain.
Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
[TBL] [Abstract][Full Text] [Related]
28. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
[TBL] [Abstract][Full Text] [Related]
29. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of hypothalamic AMPK on serine(485/491) related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine.
Kim H; Park M; Lee SK; Jeong J; Namkoong K; Cho HS; Park JY; Lee BI; Kim E
Psychopharmacology (Berl); 2014 Oct; 231(20):4059-69. PubMed ID: 24733236
[TBL] [Abstract][Full Text] [Related]
31. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
Deng C; Lian J; Pai N; Huang XF
J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
[TBL] [Abstract][Full Text] [Related]
32. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats.
Nakhate KT; Subhedar NK; Kokare DM
Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565
[TBL] [Abstract][Full Text] [Related]
33. Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats.
Zhang Q; He M; Deng C; Wang H; Lian J; Huang XF
Int J Neuropsychopharmacol; 2014 May; 17(5):807-18. PubMed ID: 24468236
[TBL] [Abstract][Full Text] [Related]
34. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
Choi S; DiSilvio B; Unangst J; Fernstrom JD
Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
[TBL] [Abstract][Full Text] [Related]
35. Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine.
McDonnell DP; Kryzhanovskaya LA; Zhao F; Detke HC; Feldman PD
Hum Psychopharmacol; 2011 Aug; 26(6):422-33. PubMed ID: 21823172
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
Skrede S; Fernø J; Vázquez MJ; Fjær S; Pavlin T; Lunder N; Vidal-Puig A; Diéguez C; Berge RK; López M; Steen VM
Int J Neuropsychopharmacol; 2012 Mar; 15(2):163-79. PubMed ID: 21854679
[TBL] [Abstract][Full Text] [Related]
37. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
[TBL] [Abstract][Full Text] [Related]
38. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine.
Kryzhanovskaya LA; Xu W; Millen BA; Acharya N; Jen KY; Osuntokun O
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):157-65. PubMed ID: 22372514
[TBL] [Abstract][Full Text] [Related]
39. Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent model.
Horska K; Kucera J; Drazanova E; Kuzminova G; Amchova P; Hrickova M; Ruda-Kucerova J; Skrede S
Biomed Pharmacother; 2024 Jul; 176():116763. PubMed ID: 38805968
[TBL] [Abstract][Full Text] [Related]
40. Selective glucocorticoid receptor (type II) antagonists prevent weight gain caused by olanzapine in rats.
Belanoff JK; Blasey CM; Clark RD; Roe RL
Eur J Pharmacol; 2011 Mar; 655(1-3):117-20. PubMed ID: 21269600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
